Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Segway use in individuals with multiple sclerosis.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
Capture-Recapture as a Potentially Useful Procedure for Assessing Prevalence of Multiple Sclerosis: Methodologic Exercise Using Portuguese Data.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.
Low dose naltrexone therapy in multiple sclerosis.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
A touch of MS: Therapeutic mislabeling.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
A randomized trial of stress management for the prevention of new brain lesions in MS.

Pages